AKT1 and cancer: Notable effects of doxycycline have been observed in osteosarcoma, where it activates Notch1, a transmembrane receptor and cell differentiation regulator, and inhibits the PI3K/Akt/mTOR signaling pathway, resulting in S-phase arrest, apoptosis, and autophagy of cancer cells [85].